Logo

    series d

    Explore " series d" with insightful episodes like "WiserWednesday.com #S03.E01 - An Ultraleap to Series D with Tom Carter", "NFXBio: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D" and "Scaleup lessons at Series D and beyond with Eric Santos, CEO, Resultados Digitais" from podcasts like ""WiserWednesday - Scale up your Startup", "The NFX Podcast" and "The SaaS Revolution Show"" and more!

    Episodes (3)

    WiserWednesday.com #S03.E01 - An Ultraleap to Series D with Tom Carter

    WiserWednesday.com #S03.E01 - An Ultraleap to Series D with Tom Carter
    Thank you Tom for an excellent discussion on his journey to Series D (a feat only achieved by a few people on the planet). We dive into the human side of being a founder and how challenging that is with a young family and the excitement on Tom & his cofounders eureka moment when they realised this would actually work. From Bristol University PhD spin-out to CES Vegas & HQ in San Fransisco with an acquisition in between, tom share why we should make sure in life that we take the leap, realise we will step on rakes & why the trick to succeeding is to work (& sleep) like a lion! As always, your host is James Potten.

    NFXBio: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D

    NFXBio: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D
    Today, Mammoth Biosciences announced their series C and D at more than a $1B valuation. Mammoth is a startup story that Founders should be following because there is so much to learn from their path from the lab to unicorn status. At no other time in modern history has the need for science to lead our society toward a better future been more apparent and immense. We can meet this need by investing in the next generation of tech-bio companies like Mammoth. NFX led Mammoth’s Pre-Seed and Seed rounds, co-led the Series A, and has invested in every round including today’s Series D. We even helped them name the company. Mammoth is the poster child for the NFX strategy of using network effects to build bio platforms — this approach to building tech-bio businesses should allow them to get 10x the size of a normal bio company. It’s also a great example of how NFX Bio supports Scientist-Founders as they become great Founders and CEOs after they leave the lab. Listen in with Omri Drory, head of NFX Bio, and Partner James Currier as they take an inside look with Mammoth’s Co-Founder & CEO Trevor Martin at his journey from idea to unicorn — for the benefit of up-and-coming Scientist-Founders worldwide.

    Scaleup lessons at Series D and beyond with Eric Santos, CEO, Resultados Digitais

    Scaleup lessons at Series D and beyond with Eric Santos, CEO, Resultados Digitais
    Eric Santos, CEO and founder of Resultados Digitais (RD) is this week’s guest on The SaaS Revolution Show. He shares his learnings from raising their series C and D rounds of funding, including how the company's growth strategies have developed during that time. Check out the other ways SaaStock is serving SaaS founders 🇺🇸 SaaStock USA 2024: 1500+ B2B SaaS founders, investors and operators are joining us in the 'Silicon Hills' of Austin, Texas for three days of SaaS magic (https://www.saastock.com/saastock-usa/) 🇮🇪 SaaStock Dublin 2024: The largest concentration of SaaS decision makers in one place for three days of networking, connecting, and learning all things SaaS (https://www.saastock.com/saastock-2024/) 🤝 SaaStock Founder Membership: A private members group of B2B SaaS founders between $100K - $10M ARR who are committed to growth and helping others (https://www.saastock.com/founder-membership/) 🌎 SaaStock Local: Monthly meet-ups in cities all around the world, bringing together SaaS enthusiasts and experts to discuss the most pressing topics in SaaS (https://local.saastock.com/home
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io